SC 13G/A: AMGEN INC
Ticker: AMGN · Form: SC 13G/A · Filed: 2024-08-23T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by AMGEN INC.
Risk Assessment
Risk Level: low
From the Filing
0001193125-24-206196.txt : 20240823 0001193125-24-206196.hdr.sgml : 20240823 20240823162027 ACCESSION NUMBER: 0001193125-24-206196 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240823 DATE AS OF CHANGE: 20240823 GROUP MEMBERS: AMGEN SINGAPORE MANUFACTURING PTE. LTD. GROUP MEMBERS: AMGEN TECHNOLOGY, LTD GROUP MEMBERS: ONYX PHARMACEUTICALS, INC. GROUP MEMBERS: SAGA INVESTMENTS COOPERATIEF U.A. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NewAmsterdam Pharma Co N.V. CENTRAL INDEX KEY: 0001936258 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-93833 FILM NUMBER: 241236587 BUSINESS ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NARRDEN STATE: P7 ZIP: 1411 DC BUSINESS PHONE: 35 206 2971 MAIL ADDRESS: STREET 1: GOOIMEER 2-35 CITY: NARRDEN STATE: P7 ZIP: 1411 DC FORMER COMPANY: FORMER CONFORMED NAME: NewAmsterdam Pharma Co B.V. DATE OF NAME CHANGE: 20220701 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 SC 13G/A 1 d856951dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* NewAmsterdam Pharma Company N.V. (Name of Issuer) Ordinary Shares, nominal value EUR 0.12 per share (Title of Class of Securities) N62509109 (CUSIP Number) August 22, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 2 of 10 CUSIP No. N62509109  1)   Names of reporting persons.  SAGA INVESTMENTS COÖPERATIEF U.A.  2)  Check the appropriate box if a member of a group (see instructions)  (a) ☐  (b) ☐  3)  SEC use only  4)  Citizenship or place of organization  Netherlands Number of shares  beneficially  owned by each reporting person with: 5.   Sole voting power  0 6.  Shared voting power  0 7.  Sole dispositive power  0 8.  Shared dispositive power  0  9)   Aggregate amount beneficially owned by each reporting person  0 10)  Check if the aggregate amount in Row (9) excludes certain shares (see instructions)  ☐ 11)  Percent of class represented by amount in Item 9  0.0% 12)  Type of reporting person (see instructions)  CO Page 3 of 10 CUSIP No. N62509109  1)   Names of reporting persons.  AMGEN SINGAPORE MANUFACTURING PTE.